These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9150936)
21. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908 [TBL] [Abstract][Full Text] [Related]
22. Micropreparative gel electrophoresis of low-molecular-weight peptides: purification of highly insoluble amyloid peptide fragments. Baumann M; Golabek A; Lalowski M; Wisniewski T Anal Biochem; 1996 May; 236(2):191-8. PubMed ID: 8660494 [TBL] [Abstract][Full Text] [Related]
23. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Kawahara M; Muramoto K; Kobayashi K; Mori H; Kuroda Y Biochem Biophys Res Commun; 1994 Jan; 198(2):531-5. PubMed ID: 7507666 [TBL] [Abstract][Full Text] [Related]
24. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683 [TBL] [Abstract][Full Text] [Related]
25. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458 [TBL] [Abstract][Full Text] [Related]
27. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein. Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314 [TBL] [Abstract][Full Text] [Related]
28. Electrophoretic separation and immunoblotting of aβ(1-40) and aβ (1-42). Staufenbiel M; Paganetti PA Methods Mol Med; 2000; 32():91-9. PubMed ID: 21318513 [TBL] [Abstract][Full Text] [Related]
29. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
30. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. De Strooper B; Saftig P; Craessaerts K; Vanderstichele H; Guhde G; Annaert W; Von Figura K; Van Leuven F Nature; 1998 Jan; 391(6665):387-90. PubMed ID: 9450754 [TBL] [Abstract][Full Text] [Related]
31. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
32. Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E. Golabek AA; Kida E; Walus M; Perez C; Wisniewski T; Soto C Biophys J; 2000 Aug; 79(2):1008-15. PubMed ID: 10920030 [TBL] [Abstract][Full Text] [Related]
34. Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897. Anderson JJ; Holtz G; Baskin PP; Turner M; Rowe B; Wang B; Kounnas MZ; Lamb BT; Barten D; Felsenstein K; McDonald I; Srinivasan K; Munoz B; Wagner SL Biochem Pharmacol; 2005 Feb; 69(4):689-98. PubMed ID: 15670587 [TBL] [Abstract][Full Text] [Related]
35. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
36. Amyloid beta protein and its 3-kDa fragment are present in the axoplasm fraction of the white matter in human brain. Tokuda T; Kametani F; Tanaka K; Sahara N; Ikeda S; Yanagisawa N Biochem Biophys Res Commun; 1996 Jun; 223(1):165-9. PubMed ID: 8660364 [TBL] [Abstract][Full Text] [Related]
37. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Koudinov A; Matsubara E; Frangione B; Ghiso J Biochem Biophys Res Commun; 1994 Dec; 205(2):1164-71. PubMed ID: 7802646 [TBL] [Abstract][Full Text] [Related]